AlphaStar Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,701
Closed -$10M 393
2021
Q3
$10M Buy
15,701
+6,113
+64% +$4.11M 0.68% 28
2021
Q2
$6.05M Buy
9,588
+201
+2% +$111K 0.78% 26
2021
Q1
$4.59M Buy
9,387
+1,578
+20% +$791K 0.71% 33
2020
Q4
$3.82M Buy
+7,809
New +$3.49M 0.65% 31
2018
Q4
Sell
-808
Closed -$202K 222
2018
Q3
$202K Buy
+808
New +$196K 0.06% 224

Other funds holding IDXX

AlphaStar Capital Management's IDXX Position: Q4 2021 in Review

AlphaStar Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 15,701 shares — an estimated $10M sold.

AlphaStar Capital Management first reported a position in IDXX in Q3 2018 and held it in 5 quarters. The position peaked at $10M in Q3 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • AlphaStar Capital Management reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • AlphaStar Capital Management sold 15,701 Idexx Laboratories shares in Q4 2021, an estimated $10M.
  • AlphaStar Capital Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 5 quarters.
  • AlphaStar Capital Management's Idexx Laboratories position peaked at $10M in Q3 2021.
  • 1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on AlphaStar Capital Management's 13F filing for Q4 2021, filed 4 Feb 2022.